Advancing Care Through Genomic and Technological Innovation
Find clear, expert answers to your questions about our neuroscience and AI solutions.
What technologies does Relatix Bio use to address Neurological Diseases?
We combine neuroscience, genomics, and artificial intelligence to develop precise diagnostic and treatment tools for Neurological Diseases. Following on from the large advances recently made with understanding autism, Parkinson’s, schizophrenia and ADHD, we are now looking at a much larger set of diseases/states of neurodiversity, many which are very poorly understood, difficult to diagnose correctly, and many which are very under-diagnosed.
How does Relatix Bio’s approach reduce the stigma around Neurodiversity and Neurological Diseases?
By advancing understanding through integrated science, we promote awareness and foster empathy, helping to diminish societal stigma. In everything we do, we aim to be led by the people with these conditions, and their perception of reality, and their everyday life. We aim to make their lives easier, more fulfilling, and improve their integration into society. Throughout history, so many people have been unnecessarily punished for things that they’ve not been able to change, from being left-handed, to inability to learn how to read. This needs to change! We all need support, not punishment. We focus on abilities, communication and adaptation, as a way for us all to understand each other a little bit better.
Can your solutions predict the progression of Neurological Diseases?
Yes, we build AI models to analyze genomic and clinical data to forecast disease trajectories and personalize care strategies.
How can I access Relatix Bio’s services?
Services are available through our email sign-up. Head to “Participate” to be part of our study cohorts, or send us an email if you’d like to partner with us.